No Data
No Data
AngioDynamics, Inc. (NASDAQ:ANGO) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
It's been a pretty great week for AngioDynamics, Inc. (NASDAQ:ANGO) shareholders, with its shares surging 13% to US$6.95 in the week since its latest full-year results. It looks like a
AngioDynamics, Inc. (NASDAQ:ANGO) Held Back By Insufficient Growth Even After Shares Climb 26%
AngioDynamics, Inc. (NASDAQ:ANGO) shareholders have had their patience rewarded with a 26% share price jump in the last month. Unfortunately, the gains of the last month did little to right the
When Will AngioDynamics, Inc. (NASDAQ:ANGO) Breakeven?
AngioDynamics Price Target Cut to $13.00/Share From $18.00 by Canaccord Genuity
AngioDynamics Price Target Cut to $13.00/Share From $18.00 by Canaccord
AngioDynamics Is Maintained at Buy by Canaccord Genuity
AngioDynamics Is Maintained at Buy by Canaccord
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $13
CCORF analyst John Young CFA maintains $AngioDynamics(ANGO.US)$ with a buy rating, and adjusts the target price from $18 to $13.According to TipRanks data, the analyst has a success rate of 33.3%
No Data